FC11409B | CAS#1380411-57-3 | CAIX Inhibitor

MedKoo Cat#: 563977 | Name: FC11409B

Description:

WARNING: This product is for research use only, not for human or veterinary use.

FC11409B is a CAIX inhibitor, inhibiting breast cancer invasion and metastasis.

Chemical Structure

FC11409B

CAS#1380411-57-3 (BF4)

Theoretical Analysis

MedKoo Cat#: 563977

Name: FC11409B

CAS#: 1380411-57-3 (BF4)

Chemical Formula: C29H23BF4N2O3S

Exact Mass: 566.1459

Molecular Weight: 566.38

Elemental Analysis: C, 61.50; H, 4.09; B, 1.91; F, 13.42; N, 4.95; O, 8.47; S, 5.66

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

1380411-57-3 (BF4) 1380411-56-2 (free base)

Synonym

FC11409B; FC-11409B; FC 11409B

IUPAC/Chemical Name

2,4,6-Triphenyl-1-(4-(sulfamoyloxy)phenyl)pyridin-1-ium tetrafluoroborate

InChi Key

ODRMDUOSDISTHM-UHFFFAOYSA-N

InChi Code

InChI=1S/C29H23N2O3S.BF4/c30-35(32,33)34-27-18-16-26(17-19-27)31-28(23-12-6-2-7-13-23)20-25(22-10-4-1-5-11-22)21-29(31)24-14-8-3-9-15-24;2-1(3,4)5/h1-21H,(H2,30,32,33);/q+1;-1

SMILES Code

O=S(OC1=CC=C([N+]2=C(C3=CC=CC=C3)C=C(C4=CC=CC=C4)C=C2C5=CC=CC=C5)C=C1)(N)=O.F[B-](F)(F)F

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.03.00

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 566.38 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Ward C, Meehan J, Mullen P, Supuran C, Dixon JM, Thomas JS, Winum JY, Lambin P, Dubois L, Pavathaneni NK, Jarman EJ, Renshaw L, Um IH, Kay C, Harrison DJ, Kunkler IH, Langdon SP. Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models. Oncotarget. 2015 Sep 22;6(28):24856-70. doi: 10.18632/oncotarget.4498. PubMed PMID: 26259239; PubMed Central PMCID: PMC4694798.